HER2DX
Live / Registered — Registered (as of 29 Nov 2022)
What this means for you
Registered since 29 Nov 2022. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 79312395
- Registration number
- 6908909
- Mark type
- Stylized text
- Filed
- 19 Mar 2021
- Published for opposition
- 13 Sept 2022
- Registered
- 29 Nov 2022
- Attorney of record
- Donna A. Tobin
Goods and services
- Class 001 — Chemicals: Diagnostic preparations for scientific use; reagents for research purposes; reagents for medical research purposes; diagnostic reagents for scientific use or for research use; reagents for scientific use or for research use in the field of cancer; diagnostic reagents for clinical or medical laboratory use in the field of in vitro in biochemistry, clinical chemistry and microbiology
- Class 005 — Pharmaceuticals: Products for medical diagnostics, namely, medical diagnostic reagents, medical diagnostic assays for testing body fluids and tissue, and specimen collection kits comprised of swabs for medical purposes and plastic bags for transmitting medical specimens, all for use in cancer detection; diagnostic reagents for medical use; diagnostic biomarker reagents for medical purposes; medical reagents for clinical use; medical diagnostic reagents for the analysis of body fluids and tissue; diagnostic reagents for use in diagnostic testing for medical purposes; diagnostic biomarker reagents for cancer diagnosis, prognosis and treatment for medical purposes; medical diagnostic kits comprised of medical diagnostic reagents and assays for testing of body fluids and tissue, and diagnostic reagents for medical use, all for cancer diagnosis, prognosis and treatment; pharmaceutical products for the treatment of cancer; biological preparations for cancer treatment; biopharmaceutical preparations for cancer treatment; pharmaceutical preparations for the treatment of cancer for oncological use; biological reagents, namely, clinical medical reagents; diagnostic reagent kits consisting primarily of diagnostic reagents for medical use, in the field of cancer
Owner
Prosecution history
- 12 Apr 2023 — FINAL DECISION TRANSACTION PROCESSED BY IB
- 17 Mar 2023 — FINAL DISPOSITION NOTICE SENT TO IB
- 17 Mar 2023 — FINAL DISPOSITION PROCESSED
- 28 Feb 2023 — FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
- 29 Nov 2022 — NOTICE OF REGISTRATION CONFIRMATION EMAILED
- 29 Nov 2022 — REGISTERED-PRINCIPAL REGISTER
- 27 Nov 2022 — NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
- 09 Nov 2022 — NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
- 09 Nov 2022 — NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
- 03 Oct 2022 — NOTIFICATION PROCESSED BY IB
- 13 Sept 2022 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 13 Sept 2022 — PUBLISHED FOR OPPOSITION
- 07 Sept 2022 — NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
- 07 Sept 2022 — NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
- 24 Aug 2022 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED